Eagle Pharmaceuticals Inc (EGRX)
4.65
+0.14
(+3.10%)
USD |
NASDAQ |
Apr 19, 16:00
4.65
0.00 (0.00%)
After-Hours: 18:57
Eagle Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 113.41M |
| April 17, 2024 | 111.85M |
| April 16, 2024 | 115.75M |
| April 15, 2024 | 122.37M |
| April 12, 2024 | 114.45M |
| April 11, 2024 | 116.79M |
| April 10, 2024 | 115.88M |
| April 09, 2024 | 119.12M |
| April 08, 2024 | 119.77M |
| April 05, 2024 | 121.33M |
| April 04, 2024 | 122.50M |
| April 03, 2024 | 117.96M |
| April 02, 2024 | 113.28M |
| April 01, 2024 | 116.79M |
| March 28, 2024 | 122.89M |
| March 27, 2024 | 119.90M |
| March 26, 2024 | 120.29M |
| March 25, 2024 | 120.81M |
| March 22, 2024 | 120.42M |
| March 21, 2024 | 122.76M |
| March 20, 2024 | 128.61M |
| March 19, 2024 | 126.27M |
| March 18, 2024 | 127.83M |
| March 15, 2024 | 133.41M |
| March 14, 2024 | 132.11M |
| Date | Value |
|---|---|
| March 13, 2024 | 132.89M |
| March 12, 2024 | 129.25M |
| March 11, 2024 | 131.07M |
| March 08, 2024 | 136.01M |
| March 07, 2024 | 136.01M |
| March 06, 2024 | 137.31M |
| March 05, 2024 | 139.38M |
| March 04, 2024 | 136.53M |
| March 01, 2024 | 138.99M |
| February 29, 2024 | 130.94M |
| February 28, 2024 | 136.27M |
| February 27, 2024 | 138.48M |
| February 26, 2024 | 138.99M |
| February 23, 2024 | 136.01M |
| February 22, 2024 | 131.07M |
| February 21, 2024 | 135.75M |
| February 20, 2024 | 132.63M |
| February 16, 2024 | 132.37M |
| February 15, 2024 | 130.81M |
| February 14, 2024 | 123.02M |
| February 13, 2024 | 122.50M |
| February 12, 2024 | 127.57M |
| February 09, 2024 | 123.93M |
| February 08, 2024 | 123.93M |
| February 07, 2024 | 121.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
110.16M
Minimum
Jan 16 2024
801.67M
Maximum
Nov 01 2019
494.82M
Average
528.12M
Median
Feb 09 2022
Enterprise Value Benchmarks
| Inspire Medical Systems Inc | 6.674B |
| Baxter International Inc | 30.81B |
| NovaBay Pharmaceuticals Inc | 2.485M |
| Palatin Technologies Inc | 21.01M |
| iBio Inc | 16.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 5.164M |
| Revenue (Quarterly) | 64.65M |
| Total Expenses (Quarterly) | 54.34M |
| EPS Diluted (Quarterly) | 0.39 |